US 8133859
SCGB3A2 as a growth factor and anti-apoptotic agent
granted A61KA61K38/1709A61K38/18
Quick answer
US patent 8133859 (SCGB3A2 as a growth factor and anti-apoptotic agent) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/1709, A61K38/18, A61P, A61P11/00